Skip to content

RLX Technology stock

RLXNYSE

RLX Technology Inc., Consumer DefensiveISIN US74969N1037

$1.56▲ $0.02 (+1.3%)Closing price of 12 Nov 2026

53Score 53 out of 100, Neutral

Turn on early warning

Price and trend

31 / 100

Price history

−34% in one year

The chart shows daily closes over 6 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Below the 200-day line: the price is 22% below it.

Trend change

Since March 2026 the 50-day line has been below the 200-day line; the trend has turned down.

Momentum

Normal: the price is neither overheated nor sold off (RSI 43).

Distance to the high

The price is 39% below its 52-week high. Largest decline in 6 years: 97% (January 2021 to October 2022).

Chart figures for advanced users
SMA 50$1.69
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$2.00
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)43
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDbelow the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$1.53
The lowest closing price of the last twelve months.
Resistance$2.57
The highest closing price of the last twelve months.
Market cap
$1.88B
Div. yield
6.49%
12 months
13.7
10.0
on earnings for the next twelve months ($0.15 per share)
Fair value
$2.19

Snapshot

Computed from the data by fixed rules, no AI

  • RLX Technology Inc. belongs to the Tobacco industry (China) and, with a market value of $1.91B, is number 9 of 15 companies in its industry on MEQIRI.
  • This is an American depositary receipt (ADR).
  • In fiscal 2025 it reported revenue of $527.49M (up 43.9% year on year) and earnings of $134.43M (up 62.5%).
Show more
  • MEQIRI Score 53 out of 100 (Neutral): rank 222 of 295 in Consumer Defensive, median 62.
  • The P/E is 13.9 (Tobacco median 15.7, own median of recent years 23.3).
  • Our model puts fair value at $2.19, with the price 30% below it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Share buybacksShare count down 21% since 2020.Capital allocation 65
  • More cash than debtCash $1.35B, financial debt $36.6M.Stability 92
  • Below fair valuePrice 30% below the fair value of $2.19.Valuation 89

Weaknesses

  • Share price fell sharplyDown 33% over the last 12 months.Momentum 15
53/ 100
MEQIRI Score
Neutral

Its standout strengths are stability and valuation, while technical analysis and momentum hold the score back.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

The fundamentals are in the middle range.

Profit consistency75% of years
Cash conversion (free cash flow to earnings, 12 months)43%
ROIC (12 months)7.2%
Positive free cash flow88% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk high

How well MEQIRI warns

One of the 30% with the highest crash risk among smaller stocks.

From 2016 to 2025, 36 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What drives the risk

  • price far below its 52-week high
  • weak momentum

What lowers it

  • calm price action
  • price not overheated over the past year

Valuation

Valuation signal

Significantly undervalued
Price
$1.54
Fair value
$2.19
Gap to fair value
−30%

Closing price of 11 Nov 2026, used by the daily score.

In our model the price counts as cheap below $1.69 and expensive above $3.14 (uncertainty medium, based on the price swings of the past year).

The two parts of the fair value come to $2.63 (cash-flow model) and $1.76 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.

Calculated with a cost of equity of 7.3%. At 8.3% the fair value would be $1.97, at 6.3% it would be $2.54.

Valuation metrics

0.85
4.1
Fair value (model)
$2.19
Earnings part $1.76 (earnings per share $0.11 × 15.7)

Half from the cash-flow model, half from earnings times the industry P/E (15.7).

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

8 years

In the twelve months to 30 Jun 2026, revenue rose 53.3% on the twelve months before. Revenue has grown strongly since 2018, at around 60% per year.

Margins

8 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross 33%, operating 9%, net 25%.

Debt & balance sheet

latest quarter
0.02
> 100x
10.61
Cash & equivalents
$1.35B

The balance sheet is solid, with low debt and comfortable interest coverage.

Earnings

Next earnings
20 Nov 2026in 8 days
Last reported
14 Aug 2026below expectations

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 20266 analysts
Earnings per share
0.86+1.4%
Revenue
$914.3M+1.9%
Fiscal 20276 analysts
Earnings per share
1.06+2.6%
Revenue
$1.15B+2.4%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook confirmed

Share price after the results: −6.5%

Prudent planning: Mainland China sales are expected broadly flat for the full year and gross margin should settle back to a healthy range.

Supporting passage from the call, verbatim
“As our product mix and shipment flows normalize in the second quarter, we expect gross margin to settle back a healthy balanced range.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 14 Aug 2026 (fiscal Q2 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases or sales in the last 6 months.

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at RLX Technology

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

295 rated companies in Consumer Defensive

Rank 222 of 295
222/ 295
This company
53
Sector median
62

Categories against the sector median

ProfitabilityMedian of 295 companies59 (median 54)5 above the median
GrowthMedian of 295 companies36 (median 50)14 below the median
FundamentalsMedian of 295 companies53 (median 79)26 below the median
ValuationMedian of 290 companies with a value89 (median 65)24 above the median
StabilityMedian of 295 companies92 (median 68)24 above the median
Capital allocationMedian of 295 companies65 (median 62)3 above the median
Technical analysisMedian of 295 companies31 (median 65)34 below the median
MomentumMedian of 295 companies15 (median 60)45 below the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Tobacco

The next larger and next smaller companies by market value

All 15 Tobacco stocks

ETFs that hold RLX Technology

Held by 5 ETFs on Xetra. Shown per index: the ETF with the largest weight.

ETFWeightCostFund size
State Street SPDR MSCI Emerging Markets Small Cap UCITS ETFSPYX0.03%0.55%€516.44M
iShares MSCI EM Small Cap UCITS ETFEUNI0.03%0.74%€274.03M
iShares Core MSCI EM IMI UCITS ETFIS3N0.00%0.18%€37.17B
Show 1 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Currency
Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = CN¥6.6707)
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 13 Feb 2026)
  • Valuation signal Undervalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy